Policy | November 08, 2023
Indian pharmaceutical companies have become reliable and affordable suppliers of high-quality drugs: MoS Bhagwant Khuba
Lack of technology transfer stands out as a formidable barrier
Lack of technology transfer stands out as a formidable barrier
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Subscribe To Our Newsletter & Stay Updated
